ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
-10.87%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$44.9M
AUM Growth
–
Cap. Flow
+$44.9M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
67.05%
Holding
22
New
22
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
DaVita
DVA
|
$4.07M |
| 2 |
Edwards Lifesciences
EW
|
$3.92M |
| 3 |
Quest Diagnostics
DGX
|
$3.72M |
| 4 |
Amicus Therapeutics
FOLD
|
$3.26M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$2.86M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 84.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DaVita
DVA
$9.85B
| $4.07M | 9.07% | +56,290 | New | +$4.07M |
|
|
2
Edwards Lifesciences
EW
$47.8B
| $3.92M | 8.73% | +27,574 | New | +$3.92M |
|
|
3
Quest Diagnostics
DGX
$20.3B
| $3.72M | 8.29% | +60,520 | New | +$3.72M |
|
|
4
Amicus Therapeutics
FOLD
$2.34B
| $3.26M | 7.26% | +232,957 | New | +$3.26M |
|
|
NVRO
5
DELISTED
NEVRO CORP.
NVRO
| $2.86M | 6.37% | +61,660 | New | +$2.86M |
|
6
Centene
CNC
$14.3B
| $2.75M | 6.13% | +50,784 | New | +$2.75M |
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $2.72M | 6.05% | +48,085 | New | +$2.72M |
|
8
Stryker
SYK
$150B
| $2.61M | 5.82% | +27,781 | New | +$2.61M |
|
9
MiMedx Group
MDXG
$1.05B
| $2.22M | 4.94% | +229,839 | New | +$2.22M |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $1.97M | 4.39% | +49,500 | New | +$1.97M |
|
|
ENDP
11
DELISTED
Endo International plc
ENDP
| $1.84M | 4.11% | +26,600 | New | +$1.84M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $1.77M | 3.94% | +29,900 | New | +$1.77M |
|
|
AERI
13
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.52M | 3.39% | +85,834 | New | +$1.52M |
|
|
CLVS
14
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.51M | 3.37% | +16,458 | New | +$1.51M |
|
|
SGNT
15
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.41M | 3.15% | +92,213 | New | +$1.41M |
|
|
IPXL
16
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.35M | 3% | +38,279 | New | +$1.35M |
|
17
Vanda Pharmaceuticals
VNDA
$279M
| $1.34M | 2.98% | +118,707 | New | +$1.34M |
|
|
XNPT
18
DELISTED
XENOPORT, INC.
XNPT
| $1.28M | 2.85% | +368,395 | New | +$1.28M |
|
|
ANAC
19
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.1M | 2.45% | +9,349 | New | +$1.1M |
|
|
SGYP
20
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.08M | 2.4% | +203,155 | New | +$1.08M |
|
21
Penumbra
PEN
$10.6B
| $400K | 0.89% | +9,980 | New | +$400K |
|
|
EPRS
22
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $189K | 0.42% | +42,787 | New | +$189K |
|